ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
0.18
0.00
(0.00%)
Closed July 24 4:00PM

Telo Genomics Corporation Financial Summary

The current TELO market cap is 12.81M. The company's latest EPS is CAD -0.0396 and P/E is -4.55.

Year End June 29 2023 20192020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Total Revenue 00000
Operating Income -1.05M-1.31M-1.26M-2.11M-2.82M
Net Income -1.07M-1.24M-1.07M-2.11M-2.82M
Year End June 29 2023 20192020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Total Assets 262k1.17M3.84M2.83M2.93M
Total Liabilities 1.31M393k154k230k313k
Total Equity -1.05M775k3.69M2.6M2.61M

Cash Flow

Year End June 29 2023 20192020202120222023
CAD ($)CAD ($)CAD ($)CAD ($)CAD ($)
Operating -328k-1.12M-1.11M-1.8M-2.63M
Investing N/A -8k-9k-25k-69k
Financing 280k2.03M3.83M876k2.68M
Market Cap 12.81M
Price to Earnings Ratio -4.55
Price to Sales Ratio 0
Price to Cash Ratio 4.79
Price to Book Ratio 4.9
Dividend Yield -

Share Statistics

Shares Outstanding 71.16M
Average Volume (1 week) 27.35k
Average Volume (1 Month) 28.72k
52 Week Change -29.41%
52 Week High 0.30
52 Week Low 0.105
Spread (Intraday) 0.01 (2.7%)

Company Info

Company Name Telo Genomics Corporation
Address 1200-750 west pender st
vancouver, british columbia V6C 2T8
Website https://www.telodx.com
Industry blank checks (6770)